ID   dH1cf32-iPS-2
AC   CVCL_C964
SY   dH1cf32-iPS2; DH1CF32-IPS2
DR   GEO; GSM248207
DR   GEO; GSM248208
DR   Wikidata; Q54831051
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=18157115; DOI=10.1038/nature06534;
RA   Park I.-H., Zhao R., West J.A., Yabuuchi A., Huo H.-G., Ince T.A.,
RA   Lerou P.H., Lensch M.W., Daley G.Q.;
RT   "Reprogramming of human somatic cells to pluripotency with defined
RT   factors.";
RL   Nature 451:141-146(2008).
//
RX   PubMed=18600223; DOI=10.1038/nprot.2008.92;
RA   Park I.-H., Lerou P.H., Zhao R., Huo H.-G., Daley G.Q.;
RT   "Generation of human-induced pluripotent stem cells.";
RL   Nat. Protoc. 3:1180-1186(2008).
//